XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Class A Common Stock.
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Beginning Balance at Dec. 31, 2020 $ 1 $ 123,872 $ (118,903) $ (1,099) $ 3,871
Beginning Balance, Shares at Dec. 31, 2020 1,484,362        
Issuance of common stock in February 2021 offering $ 1 8,398     8,399
Issuance of common stock in February 2021 offering (in shares) 744,936        
Issuance of warrants in February 2021 offering   2,638     2,638
Share issuance costs   (1,361)     (1,361)
Exercise of warrants   1,318     1,318
Exercise of warrants (in shares) 81,895        
Exercise of stock options   2     2
Exercise of stock options (in shares) 214        
Settlement of restricted stock units, Shares 1,028        
Stock-based compensation   3,156     3,156
Stock-based compensation (in shares) 5,337        
Other comprehensive income       (313) (313)
Net loss     (9,343)   (9,343)
Ending Balance at Jun. 30, 2021 $ 2 138,023 (128,246) (1,412) 8,367
Ending Balance, Shares at Jun. 30, 2021 2,317,772        
Beginning Balance at Mar. 31, 2021 $ 2 135,388 (122,265) (1,227) 11,898
Beginning Balance, Shares at Mar. 31, 2021 2,311,868        
Exercise of warrants   4     4
Exercise of warrants (in shares) 262        
Exercise of stock options   2     2
Exercise of stock options (in shares) 214        
Settlement of restricted stock units, Shares 91        
Stock-based compensation   2,629     2,629
Stock-based compensation (in shares) 5,337        
Other comprehensive income       (185) (185)
Net loss     (5,981)   (5,981)
Ending Balance at Jun. 30, 2021 $ 2 138,023 (128,246) (1,412) 8,367
Ending Balance, Shares at Jun. 30, 2021 2,317,772        
Beginning Balance at Dec. 31, 2021 $ 4 149,412 (137,035) (1,125) 11,256
Beginning Balance, Shares at Dec. 31, 2021 3,780,674        
Common stock issued under equity line of credit   638     638
Common stock issued under equity line of credit (in shares) 391,363        
Settlement of restricted stock units, Shares 6,274        
Common stock issued for services   34     $ 34
Common stock issued for services (in shares) 8,791       8,791
Stock-based compensation   581     $ 581
Stock-based compensation (in shares) 8,011        
Other comprehensive income       149 149
Net loss     (8,156)   (8,156)
Ending Balance at Jun. 30, 2022 $ 4 150,665 (145,191) (976) 4,502
Ending Balance, Shares at Jun. 30, 2022 4,195,113        
Beginning Balance at Mar. 31, 2022 $ 4 149,834 (141,381) (1,327) 7,130
Beginning Balance, Shares at Mar. 31, 2022 3,794,797        
Common stock issued under equity line of credit   638     638
Common stock issued under equity line of credit (in shares) 391,363        
Settlement of restricted stock units, Shares 4,690        
Common stock issued for services   14     $ 14
Common stock issued for services (in shares) 4,263       4,263
Stock-based compensation   179     $ 179
Other comprehensive income       351 351
Net loss     (3,810)   (3,810)
Ending Balance at Jun. 30, 2022 $ 4 $ 150,665 $ (145,191) $ (976) $ 4,502
Ending Balance, Shares at Jun. 30, 2022 4,195,113